Defence Therapeutics Inc.
DTCFF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $28 | $40 | $112 | $71 |
| - Cash | $1 | $0 | $3 | $1 |
| + Debt | $1 | $2 | $2 | $0 |
| Enterprise Value | $28 | $41 | $111 | $70 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$13 | -$6 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$13 | -$7 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.052 | -0.3 | -0.17 | -0.2 |
| % Growth | 82.7% | -76.5% | 15% | – |
| Operating Cash Flow | -$2 | -$4 | -$8 | -$6 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$2 | -$4 | -$8 | -$6 |